http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08291063-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f353911208ab41fd5a20f9c589a2e9b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L29-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F118-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F126-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F18-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F120-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F16-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F26-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F20-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
filingDate 1995-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10d2e8463ceb52de7cbb34c1ef8fc756
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb70017f11da74b1e476f3c05af4c73d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ed638b2e2d8b7f45a60c40eef0f420f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cdb79980b4c6b5103b3c93ac7ef83ab
publicationDate 1996-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H08291063-A
titleOfInvention Easy-to-absorb formulation and its manufacturing method
abstract (57) [Summary] [Structure] A sparingly soluble drug having a carboxyl group, polyvinylpyrrolidone, aminoalkylmethacrylate copolymer E, aminoalkylmethacrylate copolymer R An easily absorbable preparation containing at least one amino group-containing polymer selected from the group consisting of S and polyvinyl acetal diethylaminoacetate. [Effect] The dissolution rate of a poorly soluble drug having a carboxyl group can be easily increased.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013035777-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0952770-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003512402-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011201876-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5817715-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0952770-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2003072085-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011108644-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019089831-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006347939-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4632288-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0004896-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008201805-A
priorityDate 1995-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87083443
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12769847
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226594451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21889244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410550225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451113904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230221470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158

Total number of triples: 57.